PAVmed (PAVM) Price & Analysis

Compare

514 Followers

PAVM Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.30 - $1.90

Previous CloseN/A

Volume127.06K

Average Volume (3M)199.38K

Market Cap

$7.65M

Enterprise Value$66.62M

Total Cash (Recent Filing)$4.00B

Total Debt (Recent Filing)$9.31B

Price to Earnings (P/E)0.7

Beta1.69

Next Earnings

Nov 18, 2025

EPS Estimate

-0.17

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.74

Shares Outstanding17,294,619

10 Day Avg. Volume399,096

30 Day Avg. Volume199,378

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap8.71

Enterprise Value/Revenue9.50

Enterprise Value/Gross Profit-1.88

Enterprise Value/Ebitda-0.01

Forecast

1Y Price Target

$7.83

Price Target Upside1602.17% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering3

Bulls Say, Bears Say

Bulls Say

CommercializationLucid's high growth and ramp-up in commercialization will be a major catalyst for PAVmed's stock.

Regulatory ApprovalsVeris Health is developing a biopharma companion digital module to support new cancer therapeutics and will seek FDA clearance.

Bears Say

Market ChallengesPAVmed’s devices still have long development and commercialization challenges ahead, but the billion dollars market potential presents high rewards for the risks.

Revenue ProjectionsRevenue estimates for 2025 and 2026 have been lowered due to a slower expected ramp in patients.

PAVmed News

PAVmed reports Q2 non-GAAP EPS (5c) vs. (84c) last year

Reports Q2 revenue $6K vs. $979K last year. PAVmed (PAVM) had cash and cash equivalents of $4.0M as...

2d ago

PAVM

PAVmed Reports Q2 2025 Financial Results and Developments

The latest update is out from PAVmed ( ($PAVM) ). In its second quarter of 2025, PAVmed Inc....

2d ago

PAVM

Lucid Diagnostics Reports Q2 2025 Financial Results

Pavmed ( ($PAVM) ) has released its Q2 earnings. Here is a breakdown of the information Pavmed presented...

2d ago

PAVM

PAVmed Granted Nasdaq Extension for Compliance

An update from PAVmed ( ($PAVM) ) is now available. On July 29, 2025, PAVmed Inc. received a...

17d ago

PAVM

PAVmed Inc. Completes First in Human Trial of PortIO Intraosseous Infusion System

PAVmed Inc (($PAVMU)), Pavmed (($PAVM)) announced an update on their ongoing clinical study. The recent clinical study update...

2M ago

PAVM

PAVmed’s Veris Health Completes $2.5M Offering

An announcement from PAVmed ( ($PAVM) ) is now available. On June 23, 2025, Veris Health Inc., a...

2M ago

PAVM

PAVmed Holds Annual Stockholders Meeting, Approves Key Proposals

PAVmed ( ($PAVM) ) has shared an announcement. On June 18, 2025, PAVmed Inc. held its annual meeting...

2M ago

PAVM

PAVmed subsidiary Veris Health partners with Ohio State University cancer center

PAVmed’s (PAVM) majority-owned digital health subsidiary Veris Health has entered into a strategic partnership agreement with The Ohio...

2M ago

PAVM

Lucid Diagnostics to join Russell 2000, Russell 3000 indexes

Lucid Diagnostics (LUCD), a subsidiary of PAVmed (PAVM), announced that the company will join the small-cap Russell 2000...

3M ago

LUCD

PAVM

PAVmed’s Earnings Call: Optimism Amid Challenges

Pavmed (($PAVM)) has held its Q1 earnings call. Read on for the main highlights of the call. PAVmed’s...

3M ago

PAVM

PAVmed’s Strategic Advancements and Growth Potential Drive Buy Rating

Anthony Vendetti, an analyst from Maxim Group, reiterated the Buy rating on PAVmed (PAVM – Research Report). The...

3M ago

PAVM

Pavmed Inc. Reports Turnaround with Strong Q1 Earnings

Pavmed ( ($PAVM) ) has released its Q1 earnings. Here is a breakdown of the information Pavmed presented...

3M ago

PAVM

PAVmed Reports Q1 2025 Financial Results and Updates

PAVmed ( ($PAVM) ) just unveiled an update. On May 15, 2025, PAVmed Inc. provided a business update...

3M ago

PAVM

PAVmed files to sell 3.33M shares of common stock for holders

17:31 EDT PAVmed (PAVM) files to sell 3.33M shares of common stock for holders Published first on TheFly...

4M ago

PAVM

PAVM FAQ

What was PAVmed Inc’s price range in the past 12 months?

PAVmed Inc lowest stock price was $0.30 and its highest was $1.90 in the past 12 months.

What is PAVmed Inc’s market cap?

PAVmed Inc’s market cap is $7.65M.

When is PAVmed Inc’s upcoming earnings report date?

PAVmed Inc’s upcoming earnings report date is Nov 18, 2025 which is in 94 days.

How were PAVmed Inc’s earnings last quarter?

PAVmed Inc released its earnings results on Aug 14, 2025. The company reported -$0.74 earnings per share for the quarter, missing the consensus estimate of -$0.13 by -$0.61.

Is PAVmed Inc overvalued?

According to Wall Street analysts PAVmed Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does PAVmed Inc pay dividends?

PAVmed Inc does not currently pay dividends.

What is PAVmed Inc’s EPS estimate?

PAVmed Inc’s EPS estimate is -0.17.

How many shares outstanding does PAVmed Inc have?

PAVmed Inc has 17,294,619 shares outstanding.

What happened to PAVmed Inc’s price movement after its last earnings report?

PAVmed Inc reported an EPS of -$0.74 in its last earnings report, missing expectations of -$0.13. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of PAVmed Inc?

Among the largest hedge funds holding PAVmed Inc’s share is Cruiser Capital Advisors, Llc. It holds PAVmed Inc’s shares valued at 0.

Company Description

PAVmed Inc

PAVmed Inc. is a diversified medical technology company focused on the development and commercialization of innovative medical devices and diagnostics. Operating primarily in the healthcare sector, PAVmed specializes in the creation of products that address unmet clinical needs across various medical fields, including gastroenterology, surgery, and cardiology. Its core products include the EsoCheck device for esophageal cell collection and the CarpX device for minimally invasive carpal tunnel release, among others.

PAVmed (PAVM) Earnings & Revenues

Historic Earnings Reports

PAVM Company Deck

PAVM Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call presented a mix of positive developments, such as a strengthened balance sheet, progress in diagnostic and health platforms, and strategic expansion plans. However, the company still faces challenges, particularly in securing Medicare coverage for Lucid and navigating potential market volatility. Overall, the positives and strategic directions appear to slightly outweigh the uncertainties and dependencies.View all PAVM earnings summaries

PAVM Stock 12 Month Forecast

Average Price Target

$7.83

▲(1602.17% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"20":"$20","-1":"-$1","4.25":"$4.25","9.5":"$9.5","14.75":"$14.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":19,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$19.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.83,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,4.25,9.5,14.75,20],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.61,2.0246153846153847,3.439230769230769,4.853846153846154,6.268461538461539,7.683076923076923,9.097692307692308,10.512307692307692,11.926923076923076,13.34153846153846,14.756153846153845,16.17076923076923,17.585384615384616,{"y":19,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.61,1.1653846153846152,1.7207692307692306,2.276153846153846,2.8315384615384613,3.3869230769230767,3.942307692307692,4.497692307692308,5.053076923076923,5.608461538461539,6.163846153846154,6.719230769230769,7.274615384615385,{"y":7.83,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.61,0.6015384615384616,0.5930769230769231,0.5846153846153846,0.5761538461538461,0.5676923076923077,0.5592307692307692,0.5507692307692308,0.5423076923076923,0.5338461538461539,0.5253846153846153,0.5169230769230769,0.5084615384615384,{"y":0.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.87,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.74,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.31,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.45,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.8,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.91,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.03,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.11,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.63,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.74,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.7,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.82,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.61,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >